Craig Greven to Antibodies, Monoclonal
This is a "connection" page, showing publications Craig Greven has written about Antibodies, Monoclonal.
Connection Strength
0.064
-
Scott IU, Edwards AR, Beck RW, Bressler NM, Chan CK, Elman MJ, Friedman SM, Greven CM, Maturi RK, Pieramici DJ, Shami M, Singerman LJ, Stockdale CR. A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema. Ophthalmology. 2007 Oct; 114(10):1860-7.
Score: 0.064